Literature DB >> 16633071

p16INK4a overexpression independent of human papillomavirus infection in lobular endocervical glandular hyperplasia.

Akihiko Hashi1, Jia-Ying Xu, Tetsuo Kondo, Keiko Hashi, Tsutomu Yuminamochi, Masatoshi Nara, Shin-Ichi Murata, Ryohei Katoh, Kazuhiko Hoshi.   

Abstract

A high rate of human papillomavirus (HPV) infection has been reported in cervical cancer and precancerous lesions. Many studies also have shown that p16INK4a overexpression is of diagnostic value for high-risk HPV-related cervical cancer and precursors. Lobular endocervical glandular hyperplasia (LEGH) is a rare lesion of the uterine cervix. There is one report about HPV infection and few studies on p16INK4a expression in LEGH. Therefore, we 1) detected HPV infection and examined p16INK4a expression and 2) observed the relationship between HPV and p16INK4a overexpression in LEGH. The immunohistochemical expression of p16INK4a was studied in 24 cases of LEGH. HPV DNA was also evaluated in these cases using a polymerase chain reaction technique. Strong (++) p16INK4a immunoreactivity was observed in 10 (41.7%) of the 24 LEGH cases; a moderate (+) pattern was observed in 9 (37.5%) cases; a weak (+) pattern was observed in 2 (8.3%) cases; and the remaining 3 (12.5%) cases showed negative expression. Overall, p16INK4a overexpression was seen in 87.5% of the cases (21/24). HPV DNA was not detected in any of the 24 LEGH cases. These results suggest that p16INK4a overexpression is independent of HPV infection in LEGH.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16633071     DOI: 10.1097/01.pgp.0000179612.63085.70

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  1 in total

1.  P16-positive continuous minimal deviation adenocarcinoma and gastric type adenocarcinoma in a patient with Peutz-Jeghers syndrome.

Authors:  Wei-Xia Peng; Shoko Kure; Kousuke Ishino; Keisuke Kurose; Koichi Yoneyama; Ryuichi Wada; Zenya Naito
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.